See more : Fortune Brands Innovations, Inc. (FBIN) Income Statement Analysis – Financial Results
Complete financial analysis of Perrigo Company plc (PRGO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perrigo Company plc, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- AUPU Home Style Corporation Limited (603551.SS) Income Statement Analysis – Financial Results
- Pili International Multimedia Co.,Ltd. (8450.TWO) Income Statement Analysis – Financial Results
- Summit Financial Group, Inc. (SMMF) Income Statement Analysis – Financial Results
- Borqs Technologies, Inc. (BRQSF) Income Statement Analysis – Financial Results
- Foundry Fuel Products Limited (FFPL.BO) Income Statement Analysis – Financial Results
Perrigo Company plc (PRGO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.perrigo.com
About Perrigo Company plc
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.66B | 4.45B | 4.14B | 5.06B | 4.84B | 4.73B | 4.95B | 5.28B | 4.60B | 4.06B | 3.54B | 3.17B | 2.76B | 2.27B | 2.01B | 1.82B | 1.45B | 1.37B | 1.02B | 898.20M | 825.99M | 826.32M | 753.49M | 738.56M | 877.60M | 902.60M | 844.60M | 778.10M | 717.10M | 669.30M | 570.80M | 409.80M |
| Cost of Revenue | 2.98B | 3.00B | 2.72B | 3.25B | 3.06B | 2.90B | 2.97B | 3.23B | 2.89B | 2.61B | 2.26B | 2.08B | 1.81B | 1.52B | 1.41B | 1.27B | 1.05B | 969.08M | 763.71M | 630.24M | 596.08M | 614.42M | 568.99M | 561.07M | 670.80M | 641.40M | 587.10M | 547.60M | 496.60M | 456.10M | 390.10M | 278.60M |
| Gross Profit | 1.68B | 1.46B | 1.42B | 1.82B | 1.77B | 1.83B | 1.98B | 2.05B | 1.71B | 1.45B | 1.28B | 1.10B | 944.87M | 746.02M | 596.00M | 550.96M | 401.63M | 397.74M | 260.39M | 267.96M | 229.91M | 211.90M | 184.49M | 177.49M | 206.80M | 261.20M | 257.50M | 230.50M | 220.50M | 213.20M | 180.70M | 131.20M |
| Gross Profit Ratio | 36.09% | 32.69% | 34.22% | 35.85% | 36.66% | 38.71% | 40.02% | 38.86% | 37.19% | 35.65% | 36.16% | 34.53% | 34.30% | 32.88% | 29.70% | 30.24% | 27.75% | 29.10% | 25.43% | 29.83% | 27.83% | 25.64% | 24.49% | 24.03% | 23.56% | 28.94% | 30.49% | 29.62% | 30.75% | 31.85% | 31.66% | 32.02% |
| Research & Development | 122.50M | 123.10M | 122.00M | 177.70M | 187.40M | 218.60M | 167.70M | 184.00M | 187.80M | 152.50M | 115.20M | 105.77M | 89.25M | 82.51M | 77.92M | 72.19M | 66.48M | 52.29M | 38.42M | 27.72M | 23.32M | 19.89M | 17.63M | 16.31M | 14.90M | 15.90M | 13.70M | 0.00 | 0.00 | 6.20M | 0.00 | 0.00 |
| General & Administrative | 522.30M | 512.30M | 482.00M | 496.00M | 503.00M | 435.90M | 461.10M | 452.20M | 385.20M | 411.30M | 426.30M | 240.20M | 224.40M | 270.70M | 231.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 752.30M | 697.80M | 629.40M | 679.50M | 663.10M | 689.90M | 685.40M | 753.30M | 386.60M | 263.90M | 47.50M | 233.60M | 187.40M | 28.39M | 24.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.27B | 1.21B | 1.11B | 1.18B | 1.17B | 1.13B | 1.15B | 1.21B | 771.80M | 675.20M | 473.80M | 411.84M | 364.38M | 299.09M | 255.84M | 276.19M | 227.46M | 225.27M | 159.26M | 137.35M | 124.55M | 114.24M | 107.97M | 107.60M | 152.80M | 277.70M | 143.10M | 135.10M | 121.30M | 97.90M | 91.80M | 65.30M |
| Other Expenses | 131.40M | 800.00K | -417.60M | -3.70M | 4.20M | -6.10M | 10.10M | -22.70M | -343.20M | -12.40M | -900.00K | 0.00 | -42.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.13M | -16.37M | -18.60M | 22.25M | 21.10M | 29.40M | 28.60M | 27.20M | 23.70M | 18.90M | 15.40M | 12.00M |
| Operating Expenses | 1.53B | 1.33B | 815.80M | 1.35B | 1.36B | 1.35B | 1.27B | 1.39B | 959.60M | 827.70M | 589.00M | 517.62M | 411.32M | 381.60M | 333.76M | 348.38M | 293.94M | 277.56M | 197.68M | 165.07M | 144.73M | 117.77M | 107.01M | 146.16M | 188.80M | 323.00M | 185.40M | 162.30M | 145.00M | 123.00M | 107.20M | 77.30M |
| Cost & Expenses | 4.50B | 4.33B | 3.54B | 4.60B | 4.42B | 4.25B | 4.24B | 4.62B | 3.85B | 3.44B | 2.85B | 2.60B | 2.22B | 1.90B | 1.74B | 1.62B | 1.34B | 1.25B | 961.39M | 795.31M | 740.81M | 732.19M | 676.00M | 707.23M | 859.60M | 964.40M | 772.50M | 709.90M | 641.60M | 579.10M | 497.30M | 355.90M |
| Interest Income | 0.00 | 140.70M | 119.70M | 130.60M | 125.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.00K | 12.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 173.80M | 156.00M | 125.00M | 125.00M | 121.70M | 129.00M | 173.40M | 218.80M | 155.70M | 175.80M | 103.50M | 0.00 | 42.31M | 28.78M | 27.15M | 17.04M | 16.02M | 5.40M | 220.00K | 220.00K | 0.00 | 0.00 | 0.00 | 840.00K | 14.00M | 4.20M | 1.20M | 5.70M | 5.40M | 3.30M | 3.40M | 8.80M |
| Depreciation & Amortization | 359.50M | 338.60M | 312.20M | 384.80M | 396.50M | 423.60M | 444.80M | 457.00M | 548.80M | 358.90M | 160.20M | 135.32M | 102.94M | 76.13M | 70.14M | 69.23M | 58.03M | 56.60M | 34.81M | 28.45M | 26.13M | 25.61M | 23.02M | 22.25M | 21.10M | 29.40M | 28.60M | 27.20M | 23.70M | 18.90M | 15.40M | 12.00M |
| EBITDA | 575.90M | 507.20M | 915.60M | 661.90M | 612.90M | 906.00M | 1.14B | -4.18B | 754.30M | 1.21B | 939.40M | 858.90M | 713.30M | 594.10M | 411.17M | 325.31M | 288.54M | 157.13M | 177.75M | -293.90M | 131.35M | 111.30M | 113.68M | 49.42M | 59.21M | 45.17M | -32.40M | 95.40M | 99.20M | 109.10M | 88.90M | 65.90M |
| EBITDA Ratio | 12.37% | 11.49% | 21.41% | 26.01% | 20.69% | 20.35% | 28.71% | 121.02% | 16.69% | 29.81% | 24.52% | 22.48% | 21.57% | 19.42% | 16.56% | 15.19% | 11.63% | 12.86% | 47.92% | 14.62% | 13.10% | 13.37% | 15.83% | 6.69% | 4.46% | -3.59% | 11.92% | 12.26% | 13.83% | 16.30% | 15.57% | 16.08% |
| Operating Income | 151.90M | 172.80M | 573.70M | 932.40M | 604.50M | 236.50M | 598.20M | -2.00B | 747.60M | 567.00M | 679.10M | 569.23M | 490.21M | 335.90M | 247.31M | 197.48M | 98.55M | 111.33M | -330.47M | 102.90M | 85.18M | 87.00M | 40.11M | 31.33M | 18.00M | -61.80M | 72.10M | 68.20M | 75.50M | 90.20M | 73.50M | 53.90M |
| Operating Income Ratio | 3.26% | 3.88% | 13.86% | 18.41% | 12.50% | 5.00% | 12.09% | -37.87% | 16.24% | 13.96% | 19.18% | 17.94% | 17.79% | 14.80% | 12.32% | 10.84% | 6.81% | 8.15% | -32.27% | 11.46% | 10.31% | 10.53% | 5.32% | 4.24% | 2.05% | -6.85% | 8.54% | 8.76% | 10.53% | 13.48% | 12.88% | 13.15% |
| Total Other Income/Expenses | -160.20M | -218.00M | -151.70M | -259.30M | -33.80M | 54.10M | -318.10M | -2.85B | -499.60M | -412.20M | -267.80M | -71.40M | -57.20M | -39.60M | -27.25M | -43.53M | -16.91M | -5.40M | -5.40M | -433.59M | -1.66M | 1.08M | 1.36M | 3.75M | -4.99M | -14.02M | -4.20M | -1.20M | -5.70M | -5.40M | -3.30M | -3.40M |
| Income Before Tax | -8.30M | -139.10M | 258.70M | -149.40M | 171.00M | 290.60M | 280.10M | -4.85B | 248.00M | 272.60M | 607.70M | 511.99M | 450.55M | 308.19M | 203.78M | 180.44M | 89.05M | 105.94M | -330.69M | 105.98M | 86.26M | 88.35M | 43.86M | 30.49M | 4.00M | -66.00M | 70.90M | 62.50M | 70.10M | 86.90M | 70.10M | 45.10M |
| Income Before Tax Ratio | -0.18% | -3.12% | 6.25% | -2.95% | 3.53% | 6.14% | 5.66% | -91.81% | 5.39% | 6.71% | 17.17% | 16.13% | 16.35% | 13.58% | 10.15% | 9.90% | 6.15% | 7.75% | -32.29% | 11.80% | 10.44% | 10.69% | 5.82% | 4.13% | 0.46% | -7.31% | 8.39% | 8.03% | 9.78% | 12.98% | 12.28% | 11.01% |
| Income Tax Expense | -3.90M | -8.20M | 389.60M | 13.20M | 24.90M | 159.60M | 160.50M | -835.50M | 120.10M | 67.30M | 165.80M | 119.02M | 110.00M | 84.09M | 62.68M | 44.67M | 15.26M | 34.54M | 22.29M | 25.42M | 32.21M | 38.16M | 16.20M | 11.19M | 2.50M | -14.40M | 25.90M | 22.70M | 25.70M | 32.10M | 25.50M | 16.50M |
| Net Income | -12.70M | -130.90M | -130.90M | -162.60M | 146.10M | 131.00M | 119.60M | -4.01B | 127.90M | 205.30M | 441.90M | 401.61M | 339.20M | 222.55M | 144.05M | 135.77M | 73.80M | 71.40M | -352.98M | 80.57M | 54.05M | 50.20M | 27.66M | 19.30M | 1.50M | -51.60M | 45.00M | 39.80M | 44.40M | 54.80M | 44.60M | 28.60M |
| Net Income Ratio | -0.27% | -2.94% | -3.16% | -3.21% | 3.02% | 2.77% | 2.42% | -75.99% | 2.78% | 5.06% | 12.48% | 12.66% | 12.31% | 9.81% | 7.18% | 7.45% | 5.10% | 5.22% | -34.47% | 8.97% | 6.54% | 6.07% | 3.67% | 2.61% | 0.17% | -5.72% | 5.33% | 5.12% | 6.19% | 8.19% | 7.81% | 6.98% |
| EPS | -0.09 | -0.97 | -0.98 | -1.19 | 1.07 | 0.95 | 0.84 | -28.01 | 0.92 | 1.78 | 4.71 | 4.31 | 3.67 | 2.43 | 1.56 | 1.46 | 0.80 | 0.77 | -4.57 | 1.15 | 0.77 | 0.69 | 0.38 | 0.26 | 0.02 | -0.69 | 0.58 | 0.52 | 0.58 | 0.71 | 0.58 | 0.41 |
| EPS Diluted | -0.09 | -0.97 | -0.98 | -1.19 | 1.07 | 0.95 | 0.84 | -28.00 | 0.91 | 1.78 | 4.68 | 4.27 | 3.63 | 2.40 | 1.54 | 1.43 | 0.79 | 0.76 | -4.57 | 1.11 | 0.76 | 0.67 | 0.37 | 0.26 | 0.02 | -0.69 | 0.58 | 0.51 | 0.58 | 0.71 | 0.58 | 0.41 |
| Weighted Avg Shares Out | 135.30M | 134.50M | 133.60M | 136.10M | 136.00M | 137.80M | 142.30M | 143.26M | 139.30M | 115.10M | 93.90M | 93.20M | 92.30M | 91.40M | 92.18M | 93.12M | 92.23M | 92.88M | 77.31M | 70.21M | 69.75M | 73.16M | 73.65M | 73.37M | 75.00M | 74.78M | 77.43M | 77.20M | 76.55M | 77.18M | 76.90M | 69.76M |
| Weighted Avg Shares Out (Dil) | 135.30M | 134.50M | 133.60M | 136.10M | 136.50M | 138.30M | 142.60M | 143.30M | 139.80M | 115.60M | 94.50M | 94.10M | 93.50M | 92.85M | 93.63M | 95.21M | 93.81M | 94.11M | 77.31M | 72.29M | 71.16M | 74.61M | 74.09M | 73.54M | 75.00M | 74.78M | 77.43M | 77.78M | 76.55M | 77.18M | 76.90M | 69.76M |
Perrigo Company: Great Combination Of Future Growth With A Low Valuation
Perrigo's long-term growth is driven by strategic initiatives like Project Energize, aiming for $140-$170 million in annualized savings by 2026. The company's reinvestments in leadership and IT, adding 200 years of consumer experience, are crucial for sustainable growth. Perrigo's supply...
Perrigo (PRGO) International Revenue Performance Explored
Review Perrigo's (PRGO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated
PRGO reports weaker-than-expected third-quarter 2024 results. Though management updates top-line guidance for 2024, it reaffirms the bottom-line outlook.
Perrigo Company plc (PRGO) Q3 2024 Earnings Call Transcript
Perrigo Company plc (NYSE:PRGO ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - President & Chief Executive Officer Eduardo Bezerra - Chief Financial...
Perrigo (PRGO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Perrigo (PRGO) Q3 Earnings and Revenues Lag Estimates
Perrigo (PRGO) came out with quarterly earnings of $0.81 per share, missing the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.64 per share a year ago.
Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perrigo Produced and Store Brand Infant Formula Market Share Gains1; Third Quarter 2024 Infant formula Net Sales...
Perrigo to Report Q3 Earnings: Here's What to Expect
PRGO's Q3 top line is expected to have been affected by lower net product sales in the United States and unfavorable currency movements in the quarter.
Perrigo Announces Quarterly Dividend
DUBLIN , Nov. 1, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.276 per share, payable on December 17, 2024, to...
Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024
DUBLIN , Oct. 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial results on Wednesday, November 6, 2024, and host a...
Source: https://incomestatements.info
Category: Stock Reports